报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 4.61% | -20.24% | 80.08% | 18/52 | 3.55% | 澳洋健康 | 34.16% | 行业排名> |
2024-06-30 | 2.56% | 4.07% | 84.17% | 23/52 | 2.24% | 澳洋健康 | 30.56% | 行业排名> |
2024-03-31 | 1.39% | -10.9% | -73.42% | 19/52 | 1.22% | 澳洋健康 | 28.14% | 行业排名> |
2023-12-31 | 5.23% | -20.52% | -9.52% | 24/52 | 3.83% | 澳洋健康 | 39.54% | 行业排名> |
2023-09-30 | 5.78% | -35.92% | 134.96% | 23/52 | 6.78% | 澳洋健康 | 61.84% | 行业排名> |
2023-06-30 | 2.46% | -47.21% | 57.69% | 30/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
2023-03-31 | 1.56% | -42.65% | -76.29% | 26/52 | 2.55% | 澳洋健康 | 58.19% | 行业排名> |
2022-12-31 | 6.58% | -38.45% | -27.05% | 28/52 | -0.52% | *ST宜康 | 75.53% | 行业排名> |
2022-09-30 | 9.02% | 2% | 93.56% | 21/52 | 11.21% | 博腾股份 | 39.77% | 行业排名> |
2022-06-30 | 4.66% | -16.93% | 71.32% | 24/52 | 5.46% | 睿智医药 | 41.16% | 行业排名> |
2022-03-31 | 2.72% | 2% | -74.56% | 20/52 | 3.09% | 澳洋健康 | 51.68% | 行业排名> |
2021-12-31 | 10.69% | -36.93% | 90.55% | 28/52 | -6.4% | 澳洋健康 | 40.93% | 行业排名> |
2021-06-30 | 5.61% | 2% | -66.9% | 26/52 | 2.32% | 金域医学 | 43.58% | 行业排名> |
2020-12-31 | 16.95% | 2% | 2% | 20/52 | 10.94% | 金域医学 | 35.41% | 行业排名> |